Scarica l'app Stockscreener
21.90
0.90%
-0.20
Pre-mercato:
21.89
-0.010
-0.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells $7,800,077.25 in Stock - MarketBeat
Roivant Sciences (ROIV): Ramaswamy Vivek sells $67.9 million in shares By Investing.com - Investing.com South Africa
Roivant Sciences (ROIV): Ramaswamy Vivek sells $67.9 million in shares - Investing.com
Immunovant (IMVT) Is Up 14.0% After Roivant-Backed $550 Million Equity Raise For IMVT-1402Has The Bull Case Changed? - Yahoo! Finance Canada
Roivant Sciences (NASDAQ:ROIV) Given New $33.00 Price Target at The Goldman Sachs Group - MarketBeat
Roivant Sciences stock hits all-time high at 22.45 USD - Investing.com
Roivant Sciences price target raised to $32 from $29 at Leerink Partners By Investing.com - Investing.com South Africa
Roivant Sciences price target raised to $32 from $29 at Leerink Partners - Investing.com India
Roivant Sciences stock price target raised to $26 from $23 at H.C. Wainwright - Investing.com India
Immunovant (IMVT) Is Up 14.0% After $550 Million Follow-On Backed By Roivant SciencesWhat's Changed - simplywall.st
Headlands Technologies LLC Increases Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
BlackBarn Capital Partners LP Sells 125,000 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences stock holds Buy rating at Guggenheim after timeline updates By Investing.com - Investing.com South Africa
Massive Stock Acquisition: Roivant Sciences Bets Big on Immunovant - TipRanks
Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares - MarketBeat
Roivant Sciences Boosts Investor Confidence With Advancements and Financing Moves - StocksToTrade
HC Wainwright & Co. Maintains Roivant Sciences (ROIV) Buy Recommendation - Nasdaq
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m By Investing.com - Investing.com Canada
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m - Investing.com
Roivant Sciences Sees Strategic Consolidation with Key Drug Advancements - timothysykes.com
Roivant Sciences Eyes Strategic Growth: Key Analyst Updates and Development Plans - timothysykes.com
Roivant Sciences stock holds Buy rating at Guggenheim after timeline updates - Investing.com Australia
Roivant Sciences (ROIV) president Venker sells $4.17 million in shares By Investing.com - Investing.com Australia
Roivant Sciences (ROIV) president Venker sells $4.17 million in shares - Investing.com
Roivant Updates Investors On Mosliciguat Development Plans - Citeline News & Insights
Why Is Roivant Sciences Stock Gaining Thursday?Roivant Sciences (NASDAQ:ROIV) - Benzinga
Roivant Sciences (NASDAQ:ROIV) Reaches New 52-Week HighHere's Why - MarketBeat
Roivant Sciences (NASDAQ:ROIV) Reaches New 1-Year HighHere's What Happened - MarketBeat
Price-Driven Insight from (ROIV) for Rule-Based Strategy - news.stocktradersdaily.com
Roivant Sciences (ROIV) Stock Surges After 2025 Investor Day: Pipeline Milestones, Cash Runway and Analyst Forecasts - ts2.tech
HighVista Strategies LLC Sells 54,058 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant accelerates timeline for key drug programs, plans multiple launches By Investing.com - Investing.com Australia
Roivant Sciences Ltd Highlights Pipeline Progress at 2025 Investor Day - TradingView — Track All Markets
Roivant highlights continued pipeline progress and outlook for company's next phase of growth at 2025 Investor Day - marketscreener.com
Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day - marketscreener.com
Roivant (Nasdaq: ROIV) outlines 3+ launches as $550M Immunovant deal extends runway - Stock Titan
Immunovant announces $550 million stock offering and clinical program updates - Investing.com
Marshall Wace LLP Acquires 683,327 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Immunovant Announces Pricing of $550 Million Common Stock Financing - The Manila Times
Immunovant (Nasdaq: IMVT) raises $550M to support potential IMVT-1402 Graves’ launch - Stock Titan
Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investos - marketscreener.com
WINTON GROUP Ltd Has $2.35 Million Stock Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Norges Bank Invests $6.95 Million in Roivant Sciences Ltd. $ROIV - MarketBeat
A Roivant spinout bets on AI-designed drugs for immune conditions - Yahoo Finance
iSAM Funds UK Ltd Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences stock hits all-time high at $21.36 By Investing.com - Investing.com Canada
Roivant Sciences stock hits all-time high at $21.36 - Investing.com
Roivant Sciences Ltd. $ROIV is SB Investment Advisers UK Ltd.'s 3rd Largest Position - MarketBeat
88,495 Shares in Roivant Sciences Ltd. $ROIV Acquired by Franklin Resources Inc. - MarketBeat
Cash per share of Roivant Sciences Ltd. – MUN:87S - TradingView
Affinity Asset Advisors LLC Purchases 250,000 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Earnings Beat: Why Roivant Sciences Ltd stock could rally in 2025Quarterly Portfolio Report & High Return Trade Guides - moha.gov.vn
Roivant Sciences Ltd. $ROIV Position Increased by Two Seas Capital LP - MarketBeat
Roivant Sciences Ltd. $ROIV Shares Sold by Pertento Partners LLP - MarketBeat
Is Roivant Sciences Ltd. stock safe for conservative investors2025 Winners & Losers & Daily Profit Focused Screening - Newser
Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsJuly 2025 Fed Impact & High Yield Stock Recommendations - Newser
Why Roivant Sciences Ltd. stock could rally in 2025Dividend Hike & Weekly Breakout Watchlists - Newser
How Roivant Sciences Ltd. (87S) stock compares with market leadersJuly 2025 Trends & Community Verified Trade Signals - Newser
Is Roivant Sciences Ltd. (87S) stock undervalued by metricsWeekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Will Roivant Sciences Ltd. stock recover faster than peers2025 Market Overview & Capital Efficiency Focused Strategies - Newser
How Roivant Sciences Ltd. (87S) stock trades after rate cutsM&A Rumor & High Win Rate Trade Tips - Newser
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):